Blog
Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy
Kushida et al have recently published their findings of a phase 3 randomsed clinical trial (the REST-ON trial) of a once-nightly sodium oxybate administration (ON-SXB) 1.
17/06/2022